Celularity Inc (CELU)

Track

The most recent insider trading activity occurred on January 12, 2024, with a significant buy transaction by Lim Kok Thay. Prior to this, Robert J. Hariri made several buy transactions in October 2023, alongside sell transactions by Sorrento Therapeutics, Inc. The last reported transaction was a buy on January 12, 2024.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: CELU Exchange: NAS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Lim Kok Thay

1 purchase — total 5,331,335 USD

Buy 12 Jan 2024

Value US$2,030,341.33 | Price 274.66 | Shares 81,651

Hariri Robert J

Chief Executive Officer

2 purchases — total 1,484,113 USD

Buy 5 Oct 2023

Value US$2,574,534.46 | Price 212.93 | Shares 80,177

Buy 5 Oct 2023

Value US$4,013,991.95 | Price 35.95 | Shares 77,364

Sorrento Therapeutics, Inc.

1 sale — total 0 USD

Sale 5 Oct 2023

Value US$0.00 | Price 0.00 | Shares 6,307,158

Hariri Robert J

Chief Executive Officer

1 purchase — total 1,500,181 USD

Buy 29 Sep 2023

Value US$1,500,181.20 | Price 0.17 | Shares 9,064,539

Sorrento Therapeutics, Inc.

1 sale — total 0 USD

Sale 29 Sep 2023

Value US$0.00 | Price 0.00 | Shares 9,064,539

Hariri Robert J

Chief Executive Officer

1 purchase — total 17,175 USD

Buy 30 Nov 2022

Value US$17,175.00 | Price 1.72 | Shares 10,000

Hariri Robert J

Chief Executive Officer

1 purchase — total 68,400 USD

Buy 29 Nov 2022

Value US$68,400.00 | Price 1.71 | Shares 40,000

Hariri Robert J

Chief Executive Officer

1 purchase — total 69,600 USD

Buy 28 Nov 2022

Value US$69,600.00 | Price 1.74 | Shares 40,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-01-17	2024-01-12	B Purchase	3.3 Lim Kok Thay Large shareholder	81,651 +13.8% 274.66 US$2,030,341	81,651 +13.8%	274.66	US$2,030,341
2023-10-10	2023-10-05	B Purchase	2.5 Hariri Robert J Chief Executive Officer Executive Director	80,177 +3.1% 212.93 US$2,574,534	80,177 +3.1%	212.93	US$2,574,534
2023-10-10	2023-10-05	B Purchase	2.5 Hariri Robert J Chief Executive Officer Executive Director	77,364 -32.7% 35.95 US$4,013,992	77,364 -32.7%	35.95	US$4,013,992
2023-10-05	2023-10-05	S Sale	Sorrento Therapeutics, Inc. Large shareholder	6,307,158 0.00 US$0	6,307,158	0.00	US$0
2023-10-10	2023-09-29	B Purchase	2.5 Hariri Robert J Chief Executive Officer Executive Director	9,064,539 +89.3% 0.17 US$1,500,181	9,064,539 +89.3%	0.17	US$1,500,181
2023-10-05	2023-09-29	S Sale	Sorrento Therapeutics, Inc. Large shareholder	9,064,539 0.00 US$0	9,064,539	0.00	US$0
2022-11-30	2022-11-30	B Purchase	2.5 Hariri Robert J Chief Executive Officer Executive Director	10,000 +0.1% 1.72 US$17,175	10,000 +0.1%	1.72	US$17,175
2022-11-29	2022-11-29	B Purchase	2.5 Hariri Robert J Chief Executive Officer Executive Director	40,000 +0.5% 1.71 US$68,400	40,000 +0.5%	1.71	US$68,400
2022-11-28	2022-11-28	B Purchase	2.5 Hariri Robert J Chief Executive Officer Executive Director	40,000 +0.5% 1.74 US$69,600	40,000 +0.5%	1.74	US$69,600